Fundraising Fox
/Companies
Sign in

Plus Therapeutics

NASDAQ: PSTV

Austin, US · Delaware corporation

Find your way into Plus Therapeutics

Sign up to see every warm intro you have to Plus Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Plus Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cerenome operates an integrated central nervous system (CNS) oncology platform that combines precision diagnostics, targeted radiotherapeutics, and clinical data to improve how CNS cancers are detected, treated, and monitored. Evolving from work begun at Plus Therapeutics in 2020, it serves patients with CNS cancers.

AI & Machine LearningBiotechHealthtech

Founders & leadership

MH
Marc H. HedrickPresident & CEO
AS
Andrew SimsExecutive
RL
Robert LenkNamed on SEC filing
GP
Greg PetersenNamed on SEC filing
HC
Howard ClowesNamed on SEC filing
AV
An van Es-JohanssonNamed on SEC filing
RJ
Richard J. HawkinsNamed on SEC filing

Board

RA
Ronald A. AndrewsBoard director
KG
Kyle GuseBoard director

Funding

SEC filings, press & company announcements

$3.3M disclosed across 2 of 4 rounds · 2020–2026

▶$3MraisedSep 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc H. HedrickExecutive Officer, Director
  • Andrew SimsExecutive Officer
  • Howard ClowesDirector
  • An van Es-JohanssonDirector
  • Richard J. HawkinsDirector
  • Ronald A. AndrewsDirector
  • Kyle GuseDirector
Offering amount
$20M
Amount sold
$3M
First sale
Sep 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedMay 2020 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert LenkDirector
  • Greg PetersenDirector
  • Howard ClowesDirector
  • Marc H. HedrickExecutive Officer, Director
  • Andrew SimsExecutive Officer
  • An van Es-JohanssonDirector
  • Richard J. HawkinsDirector
Offering amount
$300K
Amount sold
$300K
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Plus Therapeutics do?
Cerenome operates an integrated central nervous system (CNS) oncology platform that combines precision diagnostics, targeted radiotherapeutics, and clinical data to improve how CNS cancers are detected, treated, and monitored. Evolving from work begun at Plus Therapeutics in 2020, it serves patients with CNS cancers.
How much funding has Plus Therapeutics raised?
Plus Therapeutics has disclosed $3.3M raised across 2 of its 4 known rounds.
Where is Plus Therapeutics headquartered?
Plus Therapeutics is headquartered in Austin, US.